Use of Appropriate Surveillance for Patients With Nondysplastic Barrett’s Esophagus

• Published in: Clinical gastroenterology and hepatology Vol. 16; no. 6; pp. 862 - 869.e3
• Main Authors: Tavakkoli, Anna, Appelman, Henry D., Beer, David G., Madiyal, Chaitra, Khodadost, Maryam, Nofz, Kimberly, Metko, Val, Elta, Grace, Wang, Thomas, Rubenstein, Joel H.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2018
• Subjects: Adenocarcinoma - diagnosis; Adult; Aged; Barrett Esophagus - complications; Cancer Risk; Early Detection; Early Detection of Cancer - statistics & numerical data; Endoscopy, Gastrointestinal - statistics & numerical data; Esophageal Neoplasms - diagnosis; Facilities and Services Utilization - statistics & numerical data; Female; Humans; Male; Middle Aged; PCP; Prevention; Retrospective Studies; Tertiary Care Centers; GI; BE; EGD; aOR; CI; EAC; UMBER; Early Detection; Prevention; UM; PCP; Cancer Risk; NDBE
• ISSN: 1542-3565; 1542-7714
• DOI: 10.1016/j.cgh.2018.01.052

Barrett’s esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Guidelines recommend that patients with nondysplastic BE (NDBE) undergo surveillance endoscopy every 3–5 years. We aimed to identify factors associated with surveillance endoscopy of patients with NDBE and identify trends in appropriate surveillance endoscopy of NDBE at a large tertiary care center. We performed a retrospective analysis of data from a Barrett’s Esophagus Registry, identifying patients with NDBE who underwent endoscopy in 2002 or later. We identified patients with NDBE and collected data on length of BE segment, esophageal lesions, demographic features, medications, histology findings, comorbidities, development of EAC, and dates of follow-up endoscopies. We defined appropriate surveillance as 3–5 years between 2nd and 3rd endoscopies, over-utilizers as patients who had less than 3 years between their 2nd and 3rd endoscopies, under-utilizers as patients who had more than 5 years between their 2nd and 3rd endoscopies; and never-surveilled as patients who never received a 2nd endoscopy. The primary outcomes were effects of patient factors, year, and referring providers on appropriateness of surveillance intervals. We identified 477 patients with NDBE. Only 15.9% had appropriate surveillance; 37.9% were over-utilizers 15.7% were under-utilizers and 30.4% were never surveilled. Patients were less likely to be over-surveilled if their primary care physician referred them for their 3rd endoscopy instead of a gastroenterologist (adjusted odds ratio, 0.51; 95% CI, 0.27–0.95). Male patients or those with an increased number of comorbidities were more likely to be under-surveilled or never-surveilled, whereas patients with long BE segment were more likely to be over-surveilled. In a retrospective analysis of data from a registry of patients with BE, we found that less than 16% receive appropriate surveillance for NDBE. A primary care provider in the same health system as the endoscopy clinic reduced risk of over-surveillance. This could reflect better coordination of care between specialists and primary care providers.